title: [Treatment of the massive suprachoroidal hemorrhages].
abstract: OBJECTIVE
  To analyze the anatomical and functional results obtained in post- surgical suprachoroidal hemorrhages treated from 1998 to 2000 and to review the information on the series of this complication that have been published during the last five years and which included at least 10 patients.
  
  
  METHODS
  A retrospective analysis of the medical records of patients with suprachoroidal hemorrhages at the Instituto Universitario de Oftalmobiología Aplicada (IOBA) - University Hospital of Valladolid. Bibliographic search by Med-Line/Pub Med from 1995 to 2000 was performed.
  
  
  RESULTS
  8 patients who fulfill these criteria have been treated and 8 papers, also complying with the criteria, have been found.
  
  
  CONCLUSIONS
  The functional and anatomic results of post-surgical suprachoroidal hemorrhages are still poor, even though the prognosis seems to have improved in the last 20 years. The standardized classification of massive suprachoroidal hemorrhages based on severity and the standardization of the follow-up would improve these results.
authors.affiliation: IOBA, Universidad de Valladolid, Valladolid, España.
authors.forename: J C
authors.initials: JC
authors.lastname: Pastor
authors.forename: C
authors.initials: C
authors.lastname: Baílez
authors.forename: J
authors.initials: J
authors.lastname: Aragón
authors.forename: E
authors.initials: E
authors.lastname: Rodríguez de la Rúa
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D001766:Blindness / Q000453:epidemiology / Q000209:etiology; D002387:Cataract Extraction / Q000009:adverse effects; D015897:Comorbidity; D004322:Drainage; D005130:Eye Hemorrhage / Q000145:classification / Q000453:epidemiology / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D005260:Female; D006474:Hemorrhagic Disorders / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007267:Injections; D007431:Intraoperative Complications / Q000145:classification / Q000453:epidemiology / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015814:Ocular Hypotension / Q000453:epidemiology / Q000209:etiology; D013508:Ophthalmologic Surgical Procedures / Q000009:adverse effects*; D018918:Phacoemulsification / Q000009:adverse effects; D019106:Postoperative Hemorrhage / Q000145:classification / Q000453:epidemiology / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D012163:Retinal Detachment / Q000209:etiology / Q000628:therapy; D012189:Retrospective Studies; D012307:Risk Factors; D012599:Sclerostomy; D012827:Silicone Oils / Q000627:therapeutic use; D013030:Spain; D016896:Treatment Outcome; D014821:Vitrectomy; D014822:Vitreous Body / Q000293:injuries
chemical_list: D000925:Anticoagulants; D012827:Silicone Oils; D001241:Aspirin